SUZANNE BAKEWELL, PH.D.

SUZANNE BAKEWELL, PH.D.

Suzanne Bakewell, Ph.D. is Chief Scientific Officer for Omeza. She leads research and development, clinical development, regulatory affairs and intellectual property rights for Omeza’s line of products.

Prior to joining Omeza, Suzanne was responsible for leading early-stage drug development and designing translational studies for clinical trials in both industry and academia. Trained as a physiologist, her doctoral research at Washington University focused on cancer metastasis to bone and the tumor microenvironment. As a Susan G. Komen Fellow in the Dr. Lewis Chodosh lab at the University of Pennsylvania, Suzanne studied cancer cell dormancy and disease recurrence. Suzanne’s industry experience as a principal investigator includes nanotechnology, drug delivery platforms and chemoresistance. As the Vice President of Preclinical Development at Intezyne Technologies, Suzanne was instrumental in taking IND drugs from synthesis into phase I clinical trials. Suzanne has a Graduate Certificate in Environmental Health and is a volunteer U.N. reports and grants writer to support NGOs in developing nations.